Treating new-onset cognitive complaints after risk-reducing salpingo-oophorectomy: A randomized controlled crossover trial of lisdexamfetamine

2024-11-1

Efficacy and safety of minimally invasive surgery versus open laparotomy for epithelial ovarian cancer: A systematic review and meta-analysis

2024-11-1

Body composition and peri- and postoperative complications in patients with gynaecological malignancies: A systematic review

2024-11-1

Frailty in patients with ovarian cancer and the role of healthcare access, race, and ethnicity

2024-11-1

Elucidation of the role of XBP1 in the progression of complete hydatidiform mole to invasive mole through RNA-seq

2024-11-1

The role of race/ethnicity and age in clinical trial knowledge among patients with gynecologic malignancy

2024-11-1

Impact of adjuvant therapy on oncologic outcomes in uterine-confined clear cell carcinoma of the endometrium

2024-11-1

Hispanic individuals' cervical cancer screening disparities amidst the COVID-19 pandemic

2024-11-1

Atypical placental site nodules: Clinicopathologic features, management and patient outcomes in an institutional series

2024-11-1

Clinicopathological characteristics and oncologic outcomes of patients with gestational trophoblastic neoplasia manifesting as isolated pulmonary lesions

2024-11-1

Increased TP53 somatic evolution in peritoneal washes of individuals with BRCA1 germline mutations

2024-11-1

Excellent concordance of the molecular classification between preoperative biopsy and final hysterectomy in endometrial carcinoma

2024-11-1

Initial sarcopenia and body composition changes as prognostic factors in cervical cancer patients treated with concurrent chemoradiation: An artificial intelligence-based volumetric study

2024-11-1

Quality of life and survivorship in patients with low-grade ovarian cancer

2024-11-1

Beyond the decision: Reproductive justice and cervical cancer care in a post-Dobbs era

2024-11-1

Weight-loss therapy in patients with obesity with endometrial intraepithelial neoplasia and uterine cancer

2024-11-1

Impact of management guidelines for abnormal cervical cytology on colposcopy procedure rates among young women

2024-11-1

SVIL promotes ovarian cancer progression and epithelial-mesenchymal transition under hypoxic conditions through the TGF-β/Smad pathway

2024-11-1

Glucagon-like peptide-1 (GLP-1) receptor agonists for weight management: A review for the gynecologic oncologist

2024-11-1

Serum miRNA improves the accuracy of a multivariate index assay for triage of an adnexal mass

2024-11-1

Mid-treatment MRI-based tumor response assessment for tumor recurrence and patient survival in locally advanced adenocarcinoma of the cervix: A retrospective multicenter study of KROG 23-03

2024-11-1

Physical and psychological distress amongst patients undergoing neoadjuvant chemotherapy for advanced ovarian cancer

2024-11-1

The association of maintenance hormone therapy with overall survival in advanced-stage low-grade serous ovarian carcinoma: A risk-set matched retrospective study.

2024-11-1

Defining optimal perioperative analgesia in patients undergoing laparotomy for advanced gynecologic malignancy: A randomized controlled trial

2024-11-1

Are exercise and sitting time during chemotherapy for ovarian cancer associated with treatment-related side-effects, chemotherapy completion and survival?

2024-11-1

Endometrial cancer and 2023 FIGO staging system: Not too soon, but maybe too much?

2024-10-1

Health-related quality of life, sexual function, psychological health, reproductive concerns and fertility outcome in young women treated with fertility-sparing surgery for ovarian tumors - A prospective longitudinal multicentre study

2024-10-1

Basket study of oral progesterone antagonist onapristone extended release in progesterone receptor-positive recurrent granulosa cell, low-grade serous ovarian cancer, or endometrioid endometrial cancer

2024-10-1

Vaccination with folate receptor-alpha peptides in patients with ovarian cancer following response to platinum-based therapy: A randomized, multicenter clinical trial

2024-10-1

Preclinical activity of datopotamab deruxtecan, a novel TROP2 directed antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (TROP2) in ovarian carcinoma

2024-10-1

A toolkit for a modern gynecologic oncology tissue bank

2024-10-1

The effects of Asian American Pacific Islander (AAPI) data inequities in gynecologic oncology

2024-10-1

Should we consider progression-free survival benefits enough for drug approvals in locally advanced cervical cancer?

2024-10-1

Elucidating the influences of social determinants of health on perceived overall health among African American/Black and Hispanic ovarian cancer survivors using the NIH All of Us Research Program

2024-10-1

Impact of medicaid expansion on cervical cancer screening: A state-specific difference in difference analysis

2024-10-1

Incidence of endometrial cancer in BRCA mutation carriers

2024-10-1

Response to Alexandre Andre B A da Costa et al.

2024-10-1

Molecular classification improves preoperative risk assessment of endometrial cancer

2024-10-1

The impact of estrogen receptor and L1 cell adhesion molecule expression on endometrial cancer outcome correlates with clinicopathological risk group and molecular subgroup

2024-10-1

Perioperative outcomes in gynecologic pelvic exenteration before and after implementation of an enhanced recovery after surgery program

2024-10-1

Implementation of a financial navigation program in gynecologic oncology

2024-10-1

Quality of life among borderline ovarian tumor survivors: A comparison with survivors of early-stage ovarian cancer and a cancer-free population: A cross-sectional population-based PROFILES study

2024-10-1

Nutrition's checkpoint inhibition: The impact of nutrition on immunotherapy outcomes

2024-10-1

Editorial board

2024-9-13

Financial toxicity: Moving from describing the problem toward developing interventions

2024-9-13

Concurrent POLE hotspot mutations and mismatch repair deficiency/microsatellite instability in endometrial cancer: A challenge in molecular classification

2024-9-13

Impact of immune, inflammatory and nutritional indices on outcome in patients with locally advanced cervical cancer treated with definitive (chemo)radiotherapy

2024-9-13

Results of a randomized phase II trial of paclitaxel and carboplatin versus bleomycin, etoposide and cisplatin for newly diagnosed and recurrent Chemonaive stromal ovarian tumors: An NRG oncology/gynecologic oncology group study14

2024-9-12

Systematic review – Adjuvant radiotherapy of the vulva in primary vulvar cancer

2024-9-11

Cervical squamous cell carcinoma outcomes across continents: A retrospective study

2024-9-11